Why IVF Fails: Common Causes and Underlying Factors

IVF fails more often than it succeeds, and the reasons span nearly every stage of the process, from the quality of the egg and sperm before they ever meet, to the hormonal environment of the uterus at the moment an embryo tries to implant. No single factor dominates in every case. For some couples the problem is chromosomal, for others it is uterine, and for many it is a combination of issues that individually seem minor but collectively tip the odds against pregnancy. Understanding these causes can help you and your clinic make better-informed decisions about what to investigate and what to change between cycles.

Chromosomal Problems in Embryos

The most common reason a transferred embryo fails to implant or miscarries shortly after is that it carries the wrong number of chromosomes. This condition, called aneuploidy, becomes sharply more frequent as the egg provider ages. The core issue is that the cell machinery responsible for sorting chromosomes during egg maturation becomes less reliable over time, leading to errors like chromosomes failing to separate properly or sister chromatids splitting apart too early.

¹

Preimplantation genetic testing for aneuploidy (PGT-A) can screen embryos before transfer to identify those with a normal chromosome count. Transferring a single chromosomally normal embryo at a time improves the chance of implantation while reducing the risk of multiples. However, testing has revealed that many embryos are mosaic, meaning some cells are chromosomally normal while others are not. Outcomes after transferring mosaic embryos have been surprisingly reassuring so far, with over a hundred live births documented without abnormal findings, though data remain limited.

²

Embryo Metabolism and Early Arrest

Even when chromosome counts are normal, embryos can stall in the lab before they ever reach the transfer stage. Roughly 10 to 15 percent of IVF embryos permanently arrest at the two- to four-cell stage, showing no signs of continued division.

³

A major driver of this arrest is mitochondrial dysfunction. Mitochondria in the egg supply virtually all the energy for the first several days of embryo development, and when they malfunction, the embryo runs out of fuel. Research in mouse models has shown that targeted disruption of egg mitochondria leads to developmental arrest in proportion to the severity of the damage, with affected embryos degenerating through a programmed cell-death pathway.

⁴

Studies of human eggs and embryos that failed to develop have found concrete structural problems: fewer mitochondria near the nucleus in a majority of arrested embryos, and less-developed internal membranes in the mitochondria themselves. These structural shortfalls line up with lower activity of genes involved in energy production.

⁵

Reactive oxygen species also play a role: when the embryo’s internal oxidative stress overwhelms its defenses, it can trigger permanent cell-cycle arrest. This is one reason why laboratory culture conditions, discussed later, matter so much.

Sperm DNA Fragmentation

Fertility discussions often focus on the egg, but sperm quality plays a significant role in IVF outcomes beyond simply achieving fertilization. Sperm with high levels of DNA damage can fertilize an egg normally yet still derail embryo development in the days that follow. Multiple studies have found that fertilization rates stay the same regardless of DNA fragmentation levels, but embryo quality at day three, the rate at which embryos reach the blastocyst stage, and ultimately implantation and pregnancy rates all drop when fragmentation is high.

⁶

One study using a specific marker for DNA strand breaks in sperm found that blastocyst development was about 50 percent higher when sperm DNA damage was below a threshold of 20 percent positivity compared to samples above that cutoff.

⁷

High fragmentation essentially promotes embryo arrest and activates cell-death pathways, a pattern consistent across research groups.

⁸

On the genetic side, mutations in sperm-specific genes involved in sperm development and structure have also been linked to early embryonic arrest, reinforcing that the paternal contribution to embryo viability extends well beyond the moment of fertilization.

⁹

When the Uterine Lining Is Not Ready

A healthy-looking embryo transferred into a uterus at the wrong time, or into a compromised lining, can fail to implant. The uterus has a narrow time frame, called the window of implantation, during which it is actually receptive to an embryo. Outside that window, the lining effectively rejects even chromosomally normal embryos. A large study of over 2,200 patients found that about a third had a displaced window of implantation, meaning their optimal transfer timing differed from the standard protocol.

¹⁰

Transfers that deviated from the patient’s actual receptive window saw roughly double the pregnancy loss rate compared to transfers timed within it. This makes the window of implantation one of the most overlooked and correctable causes of IVF failure, especially in women with repeated implantation failure.

¹¹

Endometrial thickness is another consideration. A very thin lining, sometimes caused by prior surgeries, infections, or poor blood flow, reduces receptivity and is a recognized challenge in IVF. Regenerative therapies are being explored for women whose lining does not respond to standard estrogen supplementation.

¹²

One small study using stem cells derived from endometrial tissue showed a dramatic increase in lining thickness and promising pregnancy rates in women who had previously failed multiple transfers due to thin endometrium.

¹³

Structural Problems Inside the Uterus

Physical abnormalities in the uterine cavity can also block implantation. Endometrial polyps, fibroids that encroach on the cavity, and hydrosalpinges (fluid-filled, blocked fallopian tubes) have all been linked to IVF failure, even when embryo quality is good.

¹⁴

Polyps reduce uterine receptivity, and removing them before starting an IVF cycle improves outcomes.

¹⁵

Hydrosalpinges are particularly damaging. The fluid that collects in the blocked tube can leak back into the uterus, where it appears to harm the endometrial lining and may physically wash embryos away from the implantation site. In animal studies, all hydrosalpinx fluid samples tested showed toxic effects on embryo development, though human-embryo studies have been less clear-cut.

¹⁶

The current understanding is that the fluid likely harms the lining’s ability to accept an embryo, or creates a mechanical barrier, rather than necessarily killing the embryo outright.

¹⁷

This is why many clinics recommend removing or disconnecting a hydrosalpinx before starting IVF.

¹⁸

Premature Progesterone Rise During Stimulation

During a stimulated IVF cycle, progesterone levels are supposed to stay low until after the trigger injection. When progesterone rises too early, it pushes the uterine lining ahead of schedule, creating a mismatch between the embryo’s developmental stage and the lining’s readiness. This does not appear to hurt embryo quality itself; the embryos look the same regardless of progesterone levels. Instead, the problem is entirely on the uterine side: the lining matures prematurely and misses its receptive window.

¹⁹

Patients with progesterone above about 1.5 ng/ml on trigger day show altered gene expression patterns in the endometrium.

²⁰

A recent study demonstrated a clear dose-response relationship: as trigger-day progesterone climbed from the lowest to the highest quartile, the proportion of patients showing premature secretory changes in the lining rose from under 5 percent to over 40 percent. Each 1 ng/ml increase in progesterone was independently associated with roughly two and a half times the odds of premature endometrial transformation.

²¹

When a premature progesterone rise is detected, many clinics choose to freeze all embryos and transfer them in a subsequent cycle, when the lining can be prepared without interference.

PCOS, Endometriosis, and Egg Quality

Polycystic ovary syndrome and endometriosis each impair IVF outcomes through somewhat different mechanisms, but both converge on the quality of the egg. In PCOS, hormonal imbalances including excess androgens and insulin resistance disrupt the follicular environment where eggs mature. Research has found higher levels of reactive oxygen species and fewer eggs with intact internal structures in women with PCOS compared to women with simple tubal infertility.

²²

Multiple endocrine and local signaling abnormalities within the ovary are thought to reduce the egg’s developmental competence, ultimately lowering pregnancy rates.

²³

Endometriosis creates a hostile ovarian microenvironment marked by inflammation, oxidative stress, and mitochondrial dysfunction, all of which can degrade egg and embryo quality.

²⁴

The presence of endometriosis in the pelvis has also been cited as a contributor to recurrent implantation failure even when embryos appear normal.

¹⁴

Body Weight and Insulin Resistance

Obesity affects IVF at multiple levels. Overweight and obese women tend to need higher doses of fertility medications, yet retrieve fewer eggs and produce fewer good-quality embryos. Research has shown that granulosa cells (the cells surrounding the egg in the follicle) express fewer receptors for the hormones used to stimulate egg growth in women with higher body mass, which helps explain why the ovaries respond sluggishly despite aggressive medication dosing.

²⁵

Insulin resistance, which often accompanies excess weight but can exist independently of it, may be the more precise culprit. A recent retrospective study compared overweight and obese women with and without insulin resistance undergoing IVF. Those with untreated insulin resistance had substantially fewer eggs retrieved, fewer good-quality embryos, and lower live birth rates. Cumulative live birth rates were about 42 percent in the insulin-resistant group compared to about 58 percent in those without insulin resistance. Importantly, the study identified insulin resistance as an independent predictor of lower live birth rates, suggesting that body weight alone is not the whole story.

²⁶

Chronic low-grade inflammation and oxidative stress in obese women further compromise embryo quality and endometrial receptivity.

²⁷

The Reproductive Tract Microbiome

An emerging area of research involves the bacteria that live in the uterus and vagina and how they affect implantation. A healthy reproductive tract is typically dominated by Lactobacillus species. When that dominance is lost and replaced by a more diverse mix of bacteria, the resulting inflammation can compromise endometrial receptivity. Both repeated implantation failure and recurrent pregnancy loss have been associated with this shift away from Lactobacillus dominance.

²⁸

Chronic endometritis, a persistent low-grade infection of the uterine lining, frequently involves reduced Lactobacillus species and colonization by pathogenic bacteria. Antibiotic treatment can restore the microbial balance and has been reported to improve implantation rates. Combined antibiotic and probiotic approaches are also being explored for women with non-Lactobacillus-dominated uterine microbiota and repeated implantation failure.

²⁹

Some clinics now offer endometrial microbiome testing, though the field is still working out which tests are most reliable and which interventions are most effective.

³⁰

Immune System Factors

Successful pregnancy requires the immune system to tolerate the embryo, which is genetically half-foreign. When immune regulation goes awry, the body may reject the embryo rather than nurture it. Immunosuppressive therapies aimed at quieting this response have been investigated as a treatment for recurrent failure, and some evidence suggests they can address reproductive failures by managing immune cell activity.

³¹

One specific immune issue that has been studied more rigorously is antiphospholipid antibodies, immune proteins that promote abnormal blood clotting. A systematic review and meta-analysis found that their presence is associated with increased implantation failure following IVF.

³²

Immune testing and treatment remain controversial in reproductive medicine, with some clinics offering extensive panels and others arguing the evidence does not yet support routine use. If you have had multiple unexplained failures, it is worth discussing immune evaluation with your doctor, but be cautious about clinics that promise immune “fixes” without strong evidence behind specific protocols.

What Happens in the Lab

The embryology laboratory is an artificial environment that must substitute for the fallopian tube and uterus during the first several days of embryo development, and small differences in lab conditions can meaningfully affect outcomes. One well-studied variable is oxygen concentration. The natural environment of the fallopian tube has much lower oxygen levels than room air. A study comparing culture at 5 percent oxygen versus the traditional 20 percent found that the reduced-oxygen group produced significantly more good-quality embryos, with nearly 46 percent of embryos grading well compared to about 31 percent in the higher-oxygen group.

³³

This aligns with the oxidative stress mechanism discussed earlier: lower oxygen means fewer reactive oxygen species bombarding the developing embryo.

Freezing technology has also evolved. Modern vitrification (ultra-rapid freezing) causes far less damage to eggs and embryos than older slow-freeze methods, yielding nearly intact survival rates. This matters because freeze-all strategies, where all embryos are frozen and transferred in a later cycle, are increasingly common. If vitrification were not highly reliable, freeze-all cycles would carry a significant penalty.

³⁴

Genetic Variation in How Ovaries Respond to Medication

Some women respond poorly to fertility medications despite having normal egg reserves, and genetics offer one explanation. Variations in the gene for the FSH receptor affect how efficiently the ovaries respond to the hormones used in stimulation. A large multicenter study across Europe and Asia found that certain variants led to fewer eggs retrieved and a higher proportion of low responders. For example, patients carrying a specific genotype of one FSH receptor variant had nearly double the odds of being hypo-responders compared to those with the reference genotype.

³⁵

A meta-analysis confirmed that particular alleles in the FSH receptor gene raise the risk of poor ovarian response, with the strength of the association varying by ethnic background.

³⁶

Other genes involved in follicle development, including GDF9, have also been linked to response. One study found that a specific GDF9 variant was four times more common in poor responders than in normal responders.

³⁷

Pharmacogenomic approaches that tailor medication doses to a patient’s genetic profile are in early stages, but this research helps explain why two patients of the same age with similar hormone levels can have wildly different responses to the same drug protocol.

Psychological Stress and Cortisol

Whether stress causes IVF to fail is one of the most commonly asked questions, and the honest answer is that the evidence is thinner than many people assume. A systematic review looking at cortisol (a stress hormone) and IVF outcomes found significant methodological limitations across the existing studies and urged caution in drawing firm conclusions.

³⁸

That said, there is some signal: one study found that women who achieved pregnancy through IVF had lower levels of both norepinephrine and cortisol, in both blood and follicular fluid, compared to women whose cycles failed.

³⁹

The relationship between chronic stress and reproductive outcomes is plausible biologically, since stress hormones can affect blood flow to the uterus and ovaries and influence immune function. But “reduce your stress and it will work” is a vast oversimplification. If you find stress-reduction strategies like therapy, mindfulness, or exercise helpful for your well-being during treatment, they are worth pursuing on their own merits, without placing the burden of IVF success or failure on your mental state.